Nexus AG (0FGL.L)
EUR 71.3
(1.28%)
EUR 71.3
(1.28%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 24.03 Million EUR | 24.21% |
| 2022 | 19.34 Million EUR | 12.79% |
| 2021 | 17.15 Million EUR | 15.0% |
| 2020 | 14.91 Million EUR | 37.59% |
| 2019 | 10.84 Million EUR | -0.73% |
| 2018 | 10.92 Million EUR | 11.08% |
| 2017 | 9.83 Million EUR | 20.7% |
| 2016 | 8.14 Million EUR | 7.42% |
| 2015 | 7.58 Million EUR | -8.41% |
| 2014 | 8.27 Million EUR | 8.92% |
| 2013 | 7.6 Million EUR | 24.04% |
| 2012 | 6.12 Million EUR | 30.52% |
| 2011 | 4.69 Million EUR | 32.7% |
| 2010 | 3.53 Million EUR | 68.24% |
| 2009 | 2.1 Million EUR | 37.18% |
| 2008 | 1.53 Million EUR | 31.81% |
| 2007 | 1.16 Million EUR | 121.52% |
| 2006 | 525 Thousand EUR | 100.38% |
| 2005 | 262 Thousand EUR | 155.74% |
| 2004 | -470 Thousand EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 7.9 Million EUR | 35.55% |
| 2024 Q1 | 6.57 Million EUR | 1.62% |
| 2024 Q2 | 5.82 Million EUR | -11.28% |
| 2023 Q1 | 5.66 Million EUR | -2.7% |
| 2023 Q4 | 6.46 Million EUR | -3.94% |
| 2023 FY | 24.03 Million EUR | 24.21% |
| 2023 Q3 | 6.73 Million EUR | 30.15% |
| 2023 Q2 | 5.17 Million EUR | -8.72% |
| 2022 Q2 | 4.93 Million EUR | 18.31% |
| 2022 Q1 | 4.17 Million EUR | -32.94% |
| 2022 Q4 | 5.82 Million EUR | 31.81% |
| 2022 FY | 19.34 Million EUR | 12.79% |
| 2022 Q3 | 4.41 Million EUR | -10.51% |
| 2021 FY | 17.15 Million EUR | 15.0% |
| 2021 Q3 | 3.4 Million EUR | -11.52% |
| 2021 Q2 | 3.84 Million EUR | 4.51% |
| 2021 Q4 | 6.22 Million EUR | 82.76% |
| 2021 Q1 | 3.68 Million EUR | -39.93% |
| 2020 Q1 | 2.92 Million EUR | -30.71% |
| 2020 FY | 14.91 Million EUR | 37.59% |
| 2020 Q4 | 6.12 Million EUR | 131.42% |
| 2020 Q3 | 2.64 Million EUR | -17.71% |
| 2020 Q2 | 3.21 Million EUR | 10.13% |
| 2019 Q4 | 4.21 Million EUR | 77.26% |
| 2019 Q3 | 2.37 Million EUR | 65.78% |
| 2019 Q2 | 1.43 Million EUR | -48.93% |
| 2019 FY | 10.84 Million EUR | -0.73% |
| 2019 Q1 | 2.81 Million EUR | -8.05% |
| 2018 Q3 | 2.83 Million EUR | 16.8% |
| 2018 Q2 | 2.42 Million EUR | -6.65% |
| 2018 Q1 | 2.6 Million EUR | -1.29% |
| 2018 Q4 | 3.05 Million EUR | 7.76% |
| 2018 FY | 10.92 Million EUR | 11.08% |
| 2017 Q1 | 2.3 Million EUR | 24.05% |
| 2017 FY | 9.83 Million EUR | 20.7% |
| 2017 Q2 | 2.45 Million EUR | 6.24% |
| 2017 Q3 | 2.44 Million EUR | -0.37% |
| 2017 Q4 | 2.63 Million EUR | 7.95% |
| 2016 Q1 | 2.26 Million EUR | 73.17% |
| 2016 Q4 | 1.85 Million EUR | -4.42% |
| 2016 Q3 | 1.94 Million EUR | -6.36% |
| 2016 Q2 | 2.07 Million EUR | -8.3% |
| 2016 FY | 8.14 Million EUR | 7.42% |
| 2015 FY | 7.58 Million EUR | -8.41% |
| 2015 Q4 | 1.3 Million EUR | -29.22% |
| 2015 Q3 | 1.84 Million EUR | -19.65% |
| 2015 Q2 | 2.3 Million EUR | 8.18% |
| 2015 Q1 | 2.12 Million EUR | -23.08% |
| 2014 Q4 | 2.76 Million EUR | 49.08% |
| 2014 Q3 | 1.85 Million EUR | -7.81% |
| 2014 Q2 | 2.01 Million EUR | 1.62% |
| 2014 FY | 8.27 Million EUR | 8.92% |
| 2014 Q1 | 1.97 Million EUR | -6.12% |
| 2013 Q3 | 1.97 Million EUR | 18.3% |
| 2013 Q1 | 1.84 Million EUR | 23.94% |
| 2013 FY | 7.6 Million EUR | 24.04% |
| 2013 Q4 | 2.1 Million EUR | 6.57% |
| 2013 Q2 | 1.67 Million EUR | -9.28% |
| 2012 Q1 | 1.45 Million EUR | 36.34% |
| 2012 Q2 | 1.52 Million EUR | 4.75% |
| 2012 Q3 | 1.66 Million EUR | 9.66% |
| 2012 Q4 | 1.48 Million EUR | -10.85% |
| 2012 FY | 6.12 Million EUR | 30.52% |
| 2011 FY | 4.69 Million EUR | 32.7% |
| 2011 Q1 | 1.07 Million EUR | 4.47% |
| 2011 Q4 | 1.06 Million EUR | 11.4% |
| 2011 Q2 | 1.6 Million EUR | 48.98% |
| 2011 Q3 | 956 Thousand EUR | -40.25% |
| 2010 Q2 | 871 Thousand EUR | 30.39% |
| 2010 Q3 | 972 Thousand EUR | 11.6% |
| 2010 Q4 | 1.02 Million EUR | 5.76% |
| 2010 Q1 | 668 Thousand EUR | -8.87% |
| 2010 FY | 3.53 Million EUR | 68.24% |
| 2009 Q2 | 389 Thousand EUR | -15.43% |
| 2009 Q1 | 460 Thousand EUR | 0.0% |
| 2009 FY | 2.1 Million EUR | 37.18% |
| 2009 Q4 | 733 Thousand EUR | 40.69% |
| 2009 Q3 | 521 Thousand EUR | 33.93% |
| 2008 FY | 1.53 Million EUR | 31.81% |
| 2007 FY | 1.16 Million EUR | 121.52% |
| 2006 FY | 525 Thousand EUR | 100.38% |
| 2005 FY | 262 Thousand EUR | 155.74% |
| 2004 FY | -470 Thousand EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cegedim SA | -7.4 Million EUR | 424.436% |
| Guerbet SA | 23.86 Million EUR | -0.691% |
| Bastide Le Confort Médical SA | -900 Thousand EUR | 2770.111% |
| Revenio Group Oyj | 19.1 Million EUR | -25.757% |
| Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 78.239% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | 88.289% |
| LNA Santé SA | 23.4 Million EUR | -2.657% |
| Siemens Healthineers AG | 1.94 Billion EUR | 98.763% |
| Medios AG | 18.81 Million EUR | -27.757% |
| Equasens Société anonyme | 47.04 Million EUR | 48.921% |
| Stratec SE | 13.06 Million EUR | -83.906% |